LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF 10A	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	1694	10884	11155	0.9757	0.9713
MCF 10A	AZD8055	0.04	uM	LJP6	2	A12	72	hr	1694	5400	11155	0.4841	0.3917
MCF 10A	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	1694	5281	11155	0.4734	0.3791
MCF 10A	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	1694	11033	11155	0.9890	0.9870
MCF 10A	AZD7762	0.04	uM	LJP6	1	L06	72	hr	1694	9128	11155	0.8182	0.7857
MCF 10A	AZD8055	0.04	uM	LJP6	1	A12	72	hr	1694	6875	11155	0.6163	0.5476
MCF 10A	Afatinib	0.04	uM	LJP6	3	G24	72	hr	1694	1864	11155	0.1671	0.0179
MCF 10A	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	1694	10851	11155	0.9727	0.9678
MCF 10A	AT-7519	0.04	uM	LJP6	1	K06	72	hr	1694	11036	11155	0.9893	0.9874
MCF 10A	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	1694	10828	11155	0.9706	0.9654
MCF 10A	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	1694	10970	11155	0.9834	0.9804
MCF 10A	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	1694	11484	11155	1.0294	1.0347
MCF 10A	AZD7762	0.04	uM	LJP6	2	L06	72	hr	1694	9519	11155	0.8533	0.8270
MCF 10A	AZD7762	0.04	uM	LJP6	3	L06	72	hr	1694	8824	11155	0.7910	0.7536
MCF 10A	Afatinib	0.04	uM	LJP6	1	G24	72	hr	1694	1526	11155	0.1368	-0.0178
MCF 10A	Afatinib	0.04	uM	LJP6	2	G24	72	hr	1694	1790	11155	0.1605	0.0101
MCF 10A	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1694	11167	11155	1.0010	1.0012
MCF 10A	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	1694	11026	11155	0.9884	0.9863
MCF 10A	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	1694	4779	11155	0.4284	0.3260
MCF 10A	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	1694	4085	11155	0.3662	0.2527
MCF 10A	AT-7519	0.04	uM	LJP6	2	K06	72	hr	1694	11538	11155	1.0343	1.0404
MCF 10A	AT-7519	0.04	uM	LJP6	3	K06	72	hr	1694	10793	11155	0.9675	0.9617
MCF 10A	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	1694	11183	11155	1.0025	1.0029
MCF 10A	AZD8330	0.04	uM	LJP5	1	G24	72	hr	1694	2504	11155	0.2245	0.0856
MCF 10A	AZD8055	0.04	uM	LJP6	3	A12	72	hr	1694	6583	11155	0.5901	0.5167

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)